(ACMR) Acm Research - Overview
Stock: Wet Cleaning Tools, Advanced Packaging Tools, Dry Processing Tools, PECVD Tool
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 84.8% |
| Relative Tail Risk | -12.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.66 |
| Alpha | 174.11 |
| Character TTM | |
|---|---|
| Beta | 1.859 |
| Beta Downside | 1.864 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.42% |
| CAGR/Max DD | 1.23 |
Description: ACMR Acm Research January 15, 2026
ACM Research, Inc. (NASDAQ:ACMR) designs, manufactures, and sells capital equipment for semiconductor front-end wafer cleaning and advanced packaging, serving global wafer assembly customers from its Fremont, California headquarters.
The product suite includes single-wafer wet-cleaning tools such as Ultra C SAPS II/V and Ultra C TEBO II/V for defect removal on nodes ≤ 28 nm, the low-acid Ultra-C Tahoe cleaner, and a range of packaging tools (coaters, developers, photoresist strippers, scrubbers, wet etchers, copper-plating). Additional offerings comprise the e-Ultra Fn furnace, Ultra Pmax PECVD for film uniformity, and the Ultra Track 300 mm system with robotic handling and customizable software.
In FY 2023 ACMR reported roughly $140 million in revenue, a year-over-year increase of about 12 %, and a gross margin near 38 %, reflecting strong demand for low-chemical-consumption cleaning solutions amid the industry’s shift toward sub-10 nm processes. The semiconductor equipment market is projected to grow at a CAGR of ~9 % through 2027, driven by continued rollout of 5 nm/3 nm nodes and the U.S. CHIPS Act incentives that are expanding domestic fab capacity.
For a deeper, data-driven valuation, the ValueRay platform offers a granular breakdown of ACMR’s financials and peer benchmarks.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 117.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 2.96 > 1.0 |
| NWC/Revenue: 190.9% < 20% (prev 114.6%; Δ 76.28% < -1%) |
| CFO/TA 0.02 > 3% & CFO 44.4m > Net Income 117.1m |
| Net Debt (-761.9m) to EBITDA (190.6m): -4.00 < 3 |
| Current Ratio: 3.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (68.4m) vs 12m ago 2.61% < -2% |
| Gross Margin: 46.68% > 18% (prev 0.49%; Δ 4619 % > 0.5%) |
| Asset Turnover: 38.57% > 50% (prev 40.63%; Δ -2.06% > 0%) |
| Interest Coverage Ratio: 27.72 > 6 (EBITDA TTM 190.6m / Interest Expense TTM 6.39m) |
Altman Z'' 5.30
| A: 0.61 (Total Current Assets 2.36b - Total Current Liabilities 677.9m) / Total Assets 2.77b |
| B: 0.12 (Retained Earnings 346.0m / Total Assets 2.77b) |
| C: 0.08 (EBIT TTM 177.2m / Avg Total Assets 2.28b) |
| D: 0.37 (Book Value of Equity 327.6m / Total Liabilities 885.4m) |
| Altman-Z'' Score: 5.30 = AAA |
Beneish M -2.87
| DSRI: 1.02 (Receivables 527.4m/428.4m, Revenue 880.4m/729.0m) |
| GMI: 1.06 (GM 46.68% / 49.36%) |
| AQI: 0.85 (AQ_t 0.04 / AQ_t-1 0.04) |
| SGI: 1.21 (Revenue 880.4m / 729.0m) |
| TATA: 0.03 (NI 117.1m - CFO 44.4m) / TA 2.77b) |
| Beneish M-Score: -2.87 (Cap -4..+1) = A |
What is the price of ACMR shares?
Over the past week, the price has changed by +7.50%, over one month by +33.22%, over three months by +102.07% and over the past year by +171.53%.
Is ACMR a buy, sell or hold?
- StrongBuy: 4
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ACMR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48.7 | -22.1% |
| Analysts Target Price | 48.7 | -22.1% |
| ValueRay Target Price | 71.2 | 14% |
ACMR Fundamental Data Overview February 07, 2026
P/E Forward = 28.9017
P/S = 4.0082
P/B = 2.559
Revenue TTM = 880.4m USD
EBIT TTM = 177.2m USD
EBITDA TTM = 190.6m USD
Long Term Debt = 193.4m USD (from longTermDebt, last quarter)
Short Term Debt = 97.8m USD (from shortTermDebt, last quarter)
Debt = 297.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -761.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.70b USD (3.53b + Debt 297.0m - CCE 1.13b)
Interest Coverage Ratio = 27.72 (Ebit TTM 177.2m / Interest Expense TTM 6.39m)
EV/FCF = -228.1x (Enterprise Value 2.70b / FCF TTM -11.8m)
FCF Yield = -0.44% (FCF TTM -11.8m / Enterprise Value 2.70b)
FCF Margin = -1.34% (FCF TTM -11.8m / Revenue TTM 880.4m)
Net Margin = 13.30% (Net Income TTM 117.1m / Revenue TTM 880.4m)
Gross Margin = 46.68% ((Revenue TTM 880.4m - Cost of Revenue TTM 469.4m) / Revenue TTM)
Gross Margin QoQ = 42.04% (prev 48.50%)
Tobins Q-Ratio = 0.97 (Enterprise Value 2.70b / Total Assets 2.77b)
Interest Expense / Debt = 0.62% (Interest Expense 1.85m / Debt 297.0m)
Taxrate = 5.48% (2.69m / 49.1m)
NOPAT = 167.5m (EBIT 177.2m * (1 - 5.48%))
Current Ratio = 3.48 (Total Current Assets 2.36b / Total Current Liabilities 677.9m)
Debt / Equity = 0.21 (Debt 297.0m / totalStockholderEquity, last quarter 1.43b)
Debt / EBITDA = -4.00 (Net Debt -761.9m / EBITDA 190.6m)
Debt / FCF = 64.46 (negative FCF - burning cash) (Net Debt -761.9m / FCF TTM -11.8m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.13% (Net Income 117.1m / Total Assets 2.77b)
RoE = 10.96% (Net Income TTM 117.1m / Total Stockholder Equity 1.07b)
RoCE = 14.05% (EBIT 177.2m / Capital Employed (Equity 1.07b + L.T.Debt 193.4m))
RoIC = 12.77% (NOPAT 167.5m / Invested Capital 1.31b)
WACC = 11.81% (E(3.53b)/V(3.83b) * Re(12.76%) + D(297.0m)/V(3.83b) * Rd(0.62%) * (1-Tc(0.05)))
Discount Rate = 12.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.88%
Fair Price DCF = unknown (Cash Flow -11.8m)
EPS Correlation: 27.18 | EPS CAGR: 5.55% | SUE: -3.36 | # QB: 0
Revenue Correlation: 80.98 | Revenue CAGR: 31.96% | SUE: 1.12 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.41 | Chg30d=+0.033 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=2.15 | Chg30d=+0.065 | Revisions Net=+1 | Growth EPS=+18.8% | Growth Revenue=+27.2%